Indivior PLC (LON: INDV)
London
· Delayed Price · Currency is GBP · Price in GBX| Market Cap | 1.08B |
| Revenue (ttm) | 881.89M |
| Net Income (ttm) | -2.24M |
| Shares Out | 127.14M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | 6.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 258,628 |
| Open | 840.50 |
| Previous Close | 837.00 |
| Day's Range | 831.50 - 852.50 |
| 52-Week Range | 554.50 - 1,770.00 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 14, 2025 |
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUB... [Read more]
News
Indivior PLC (INDV) Trading 3.1% Higher on Nov 19
Indivior PLC (INDV) Trading 3.1% Higher on Nov 19
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024
Data show rapid initiation with once-monthly SUBLOCADE significantly improves retention in opioid use disorder (OUD) patients, especially among fentanyl-positive participants. Study also administered ...
SCOPIA CAPITAL MANAGEMENT LP Adjusts Stake in Indivior PLC
SCOPIA CAPITAL MANAGEMENT LP Adjusts Stake in Indivior PLC
Indivior jumps amid investor letter, takeover speculation (update)
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior
RICHMOND, Va. , Nov. 7, 2024 /PRNewswire/ -- Indivior PLC (NASDAQ / LSE: INDV) the Board of Directors (the "Board") of Indivior plc ("Indivior" or the "Company") notes the publication today of a lette...
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month
RICHMOND, Va., Oct. 30, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV), in recognizing Substance Abuse Prevention Month, provides an update on key findings from the last year that demonstrate th...
Indivior PLC (INDV) Q3 2024 Earnings Call Transcript
Indivior PLC (NASDAQ:INDV) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ETCompany ParticipantsJason Thompson - Head, IRMark Crossley -...
Indivior PLC 2024 Q3 - Results - Earnings Call Presentation
Indivior reports Q3 results
Indivior Announces Q3 2024 Financial Results
SLOUGH, United Kingdom and RICHMOND, Va. , Oct. 24, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending September 30, 2024.
Two Seas Capital LP Increases Stake in Indivior PLC
Two Seas Capital LP Increases Stake in Indivior PLC
Indivior: This Value Stock Has Over 100% Upside Potential If Market Share Stabilizes In 2025
Due to the extreme mis-pricing I argue Indivior offers investors great risk/reward asymmetry. Find out why INDV stock is a Strong Buy.
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Navigating Competitive Pressures and ...
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Navigating Competitive Pressures and Growth Opportunities
Preliminary Q3 2024 Indivior PLC Earnings Call Transcript
Preliminary Q3 2024 Indivior PLC Earnings Call Transcript
Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
Indivior PLC (NASDAQ: INDV) shares are trading lower after the company reported preliminary third-quarter revenue results and cut its FY24 net revenue guidance below estimates . The company expects t...
British drugmaker Indivior cuts 2024 revenue forecast, shares fall
British drugmaker Indivior on Thursday cut its 2024 net revenue forecast for the second time in three months, citing lower than expected revenues from its Sublocade treatment for opioid use disorder, ...
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
Conference Call Today at 8:00 AM US Eastern THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW I...
Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review
PDUFA date set for February 7, 2025 If approved by the FDA, label would expand to include alternative injection sites in the thigh, buttock and back of the arm for induction and maintenance as well as...
Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follo...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Indivior PLC(INDV) Shareholders
NEW YORK , Oct. 1, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Indivior PLC ("Indivior" or the "Company") (NASDAQ: INDV) of a class action securities lawsuit. CLASS DEFINITION: Th...
Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follo...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming Deadlines - INDV
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Indivior PLC ("Indivior" or the "Company") (NASDAQ:INDV) and certain officers. ...
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm.
Indivior PLC Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follo...
FINAL INDV DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Indivior PLC Investors to Join the Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior ...